Real-world outcomes and early discontinuation of foslevodopa/foscarbidopa in Parkinson’s disease

Takashi Tsuboi, Katsuo Kimura, Kensuke Ikenaka, Toru Baba, Keita Matsuura, Yuta Kajiyama, Daiki Kamiyama, Takashi Uematsu, Katsuya Abe, Keita Kakuda, Hiroyuki Takenaka, Koichi Miyashita, Akiko Saito, Masahito Mihara, Akihiro Shindo, Takafumi Hasegawa, Yasuyoshi Kimura, Fumiaki Tanaka, Nobutaka Hattori, Masahisa Katsuno, Noriko Nishikawa

Open source

DOI: 10.1007/s00415-026-13879-x
Published: 2026-05-19
Container: Journal of Neurology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00415-026-13879-x,
  title = {Real-world outcomes and early discontinuation of foslevodopa/foscarbidopa in Parkinson’s disease},
  author = {Takashi Tsuboi and Katsuo Kimura and Kensuke Ikenaka and Toru Baba and Keita Matsuura and Yuta Kajiyama and Daiki Kamiyama and Takashi Uematsu and Katsuya Abe and Keita Kakuda and Hiroyuki Takenaka and Koichi Miyashita and Akiko Saito and Masahito Mihara and Akihiro Shindo and Takafumi Hasegawa and Yasuyoshi Kimura and Fumiaki Tanaka and Nobutaka Hattori and Masahisa Katsuno and Noriko Nishikawa},
  year = {2026},
  journal = {Journal of Neurology},
  doi = {10.1007/s00415-026-13879-x},
  url = {https://doi.org/10.1007/s00415-026-13879-x}
}

RIS

TY  - JOUR
TI  - Real-world outcomes and early discontinuation of foslevodopa/foscarbidopa in Parkinson’s disease
AU  - Takashi Tsuboi
AU  - Katsuo Kimura
AU  - Kensuke Ikenaka
AU  - Toru Baba
AU  - Keita Matsuura
AU  - Yuta Kajiyama
AU  - Daiki Kamiyama
AU  - Takashi Uematsu
AU  - Katsuya Abe
AU  - Keita Kakuda
AU  - Hiroyuki Takenaka
AU  - Koichi Miyashita
AU  - Akiko Saito
AU  - Masahito Mihara
AU  - Akihiro Shindo
AU  - Takafumi Hasegawa
AU  - Yasuyoshi Kimura
AU  - Fumiaki Tanaka
AU  - Nobutaka Hattori
AU  - Masahisa Katsuno
AU  - Noriko Nishikawa
PY  - 2026
JO  - Journal of Neurology
DO  - 10.1007/s00415-026-13879-x
UR  - https://doi.org/10.1007/s00415-026-13879-x
ER  -

APA

Tsuboi, T., Kimura, K., Ikenaka, K., Baba, T., Matsuura, K., Kajiyama, Y., Kamiyama, D., Uematsu, T., Abe, K., Kakuda, K., Takenaka, H., Miyashita, K., Saito, A., Mihara, M., Shindo, A., Hasegawa, T., Kimura, Y., Tanaka, F., Hattori, N., Katsuno, M., & Nishikawa, N. (2026). Real-world outcomes and early discontinuation of foslevodopa/foscarbidopa in Parkinson’s disease. Journal of Neurology. https://doi.org/10.1007/s00415-026-13879-x

Source records

crossref · retrieved 2026-09-25T21:56:54.395Z